Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARQT
CDNA
Add up to 3 more stocks
ARQT
Arcutis Biotherapeutics, Inc.
-2.90%
$24.42-0.73Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$3.05B
52W Range
$19.30 - $31.77
CDNA
CareDx, Inc
-5.97%
$65.68-4.17Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$3.40B
52W Range
$13.95 - $70.75
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 117.12 | 31.71 |
| Forward P/E | 49.12 | 54.84 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.85 | 7.98 |
| P/S Ratio | 6.58 | 7.42 |
| P/FCF Ratio | 78.02 | 39.95 |
| EV/EBITDA | 84.26 | 195.62 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 91.1% | 70.6% |
| Operating Margin | -3.3% | -0.9% |
| Net Margin | 6.2% | 24.2% |
| ROE | 12.9% | 26.1% |
| ROA | 5.8% | 20.8% |
| ROIC | 9.9% | -0.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.92 | 4.58 |
| Quick Ratio | 2.67 | 4.51 |
| Debt/Equity | 0.52 | 0.05 |
| Interest Coverage | -1.01 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.